Legislators in a handful of states are offering bills to address the rise in the misuse of xylazine, a cheap animal sedative not intended for human consumption.
Xylazine, or “tranq,” can induce blackouts and cause lesions that sometimes result in severe infections or amputations, and it can even lead to death. The opioid overdose-reversal drug naloxone does not work on xylazine, which drug dealers often find through the dark web and other illicit channels, rather than getting it from veterinary offices. Although xylazine isn’t classified by the federal government as a controlled substance, it also isn’t approved for human use.
Several states — including Indiana, New York, South Carolina, South Dakota, Virginia and Wisconsin — are considering bills. The legislation ranges from classifying xylazine as a controlled substance to stiffening criminal penalties for possession and distribution, as well as legalizing testing strips so people who intend to take drugs can make sure they aren’t tainted by xylazine.
Other states — Florida, Ohio, Pennsylvania and West Virginia — have already added xylazine to their lists of controlled substances, which adds tighter controls to the storage and movement of the drug for veterinary use.
Full story: As xylazine surges, some lawmakers want jail time for dealers and people who use the drug • Stateline

Leave a Reply